Nur77 protects against adverse cardiac remodelling by limiting neuropeptide Y signalling in the sympathoadrenal-cardiac axis
- 30 May 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 114 (12) , 1617-1628
Abstract
Cardiac remodelling and heart failure are promoted by persistent sympathetic activity. We recently reported that nuclear receptor Nur77 may protect against sympathetic agonist-induced cardiac remodelling in mice. The sympathetic co-transmitter neuropeptide Y (NPY) is co-released with catecholamines and is a known cardiac modulator and predictor of heart failure mortality. Recently, transcriptome analyses revealed NPY as a putative target of Nur77. In this study, we assess whether Nur77 modulates adverse cardiac remodelling via NPY signalling. Nur77 represses NPY expression in the PC12 adrenal chromaffin cell line. Accordingly, NPY levels are higher in adrenal gland, plasma, and heart from Nur77-KO compared to wild-type mice. Conditioned medium from Nur77-silenced chromaffin cells and serum from Nur77-KO mice induce marked hypertrophy in cultured neonatal rat cardiomyocytes, which is inhibited by the NPY type 1 receptor (NPY1R) antagonist BIBO3304. In cardiomyocytes from Nur77-KO mice, intracellular Ca2+ is increased partially via the NPY1R. This is independent from elevated circulating NPY since cardiomyocyte-specific Nur77-deficient mice (CM-KO) do not have elevated circulating NPY, but do exhibit BIBO3304-sensitive, increased cardiomyocyte intracellular Ca2+. In vivo, this translates to NPY1R antagonism attenuating cardiac calcineurin activity and isoproterenol-induced cardiomyocyte hypertrophy and fibrosis in full-body Nur77-KO mice, but not in CM-KO mice. The cardioprotective action of Nur77 can be ascribed to both inhibition of circulating NPY levels and to cardiomyocyte-specific modulation of NPY-NPY1R signalling. These results reveal the underlying mechanism of Nur77 as a promising modifier gene in heart failure.Keywords
Funding Information
- Academic Medical Center
- Dutch Heart Foundation (CVON 2014-11 RECONNECT)
This publication has 43 references indexed in Scilit:
- Calcium Signaling and Transcriptional Regulation in CardiomyocytesCirculation Research, 2017
- Calcium Signaling and Cardiac ArrhythmiasCirculation Research, 2017
- NPY1 Receptors Participate in the Regulation of Myocardial Contractility in RatsBulletin of Experimental Biology and Medicine, 2017
- Autonomic control of the heart: going beyond the classical neurotransmittersExperimental Physiology, 2014
- Adrenergic Nervous System in Heart FailureCirculation Research, 2013
- Calcium‐regulated transcriptional pathways in the normal and pathologic heartIUBMB Life, 2011
- Expression of neuropeptide Y and its receptors Y1 and Y2 in the rat heart and its supplying autonomic and spinal sensory ganglia in experimentally induced diabetesNeuroscience, 2008
- Neuropeptide Y rapidly enhances [Ca] transients and Ca sparks in adult rat ventricular myocytes through Y receptor and PLC activationJournal of Molecular and Cellular Cardiology, 2005
- Plasma neuropeptide Y‐like immunoreactivity and catecholamines during various degrees of sympathetic activation in manClinical Physiology and Functional Imaging, 1986
- NEUROPEPTIDE TYROSINE (NPY) IMMUNOREACTIVITY IN NOREPINEPHRINE-CONTAINING CELLS AND NERVES OF THE MAMMALIAN ADRENAL GLANDEndocrinology, 1984